DK2012773T3 - Lægemidler og anvendelser deraf - Google Patents

Lægemidler og anvendelser deraf

Info

Publication number
DK2012773T3
DK2012773T3 DK07863339.3T DK07863339T DK2012773T3 DK 2012773 T3 DK2012773 T3 DK 2012773T3 DK 07863339 T DK07863339 T DK 07863339T DK 2012773 T3 DK2012773 T3 DK 2012773T3
Authority
DK
Denmark
Prior art keywords
pharmaceuticals
applications
Prior art date
Application number
DK07863339.3T
Other languages
English (en)
Inventor
James M Frincke
Christopher L Reading
Original Assignee
Harbor Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harbor Biosciences Inc filed Critical Harbor Biosciences Inc
Application granted granted Critical
Publication of DK2012773T3 publication Critical patent/DK2012773T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
DK07863339.3T 2006-04-22 2007-04-23 Lægemidler og anvendelser deraf DK2012773T3 (da)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US79379206P 2006-04-22 2006-04-22
US84311206P 2006-09-08 2006-09-08
US82556906P 2006-09-13 2006-09-13
US82556406P 2006-09-13 2006-09-13
US82984806P 2006-10-17 2006-10-17
US86639506P 2006-11-17 2006-11-17
US86670006P 2006-11-21 2006-11-21
US86804206P 2006-11-30 2006-11-30
US88500307P 2007-01-15 2007-01-15
US88805807P 2007-02-02 2007-02-02
PCT/US2007/067235 WO2008039566A2 (en) 2006-04-22 2007-04-23 Drugs and uses

Publications (1)

Publication Number Publication Date
DK2012773T3 true DK2012773T3 (da) 2012-09-24

Family

ID=39230844

Family Applications (2)

Application Number Title Priority Date Filing Date
DK07863339.3T DK2012773T3 (da) 2006-04-22 2007-04-23 Lægemidler og anvendelser deraf
DK12167186.1T DK2486924T3 (da) 2006-04-22 2007-04-23 Lægemidler og anvendelser

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK12167186.1T DK2486924T3 (da) 2006-04-22 2007-04-23 Lægemidler og anvendelser

Country Status (13)

Country Link
EP (2) EP2012773B1 (da)
JP (2) JP5130591B2 (da)
KR (1) KR20080112413A (da)
CN (1) CN103211821A (da)
AU (2) AU2007300404B2 (da)
CA (1) CA2649940C (da)
DK (2) DK2012773T3 (da)
EA (1) EA200802167A1 (da)
ES (2) ES2389743T3 (da)
HU (1) HUE042925T2 (da)
IL (1) IL194751A0 (da)
PL (2) PL2012773T3 (da)
WO (1) WO2008039566A2 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8569275B2 (en) 2002-08-28 2013-10-29 Harbor Therapeutics, Inc. Steroids having 7-oxgen and 17-heteroaryl substitution
US8354396B2 (en) 2006-11-17 2013-01-15 Harbor Therapeutics, Inc. Drug identification and treatment method
US8217025B2 (en) 2006-11-17 2012-07-10 Harbor Therapeutics, Inc. Drug screening and treatment methods
US8486926B2 (en) 2006-11-17 2013-07-16 Harbor Therapeutics, Inc. Steroid tetrol solid state forms
JP2011511011A (ja) * 2008-02-05 2011-04-07 ハーバー バイオサイエンシーズ，インコーポレイテッド 医薬的固体状態形態
PT2273994E (pt) 2008-04-03 2016-03-15 Neurmedix Inc Formas de estado sólido de um produto farmacêutico
US8309746B2 (en) 2008-06-06 2012-11-13 Harbor Therapeutics, Inc Methods for preparing 17-alkynyl-7-hydroxy steroids and related compounds
WO2011156673A2 (en) * 2010-06-10 2011-12-15 Isis Pharmaceuticals, Inc. Modulation of phosphoenolpyruvate carboxykinase-mitochondrial (pepck-m) expression
AU2011343548A1 (en) * 2010-12-17 2013-05-09 Harbor Biosciences, Inc. Steroid tetrol solid state forms-2
HUE062616T2 (hu) * 2011-09-08 2023-11-28 Sage Therapeutics Inc Neuroaktív szteroidok, készítmények és alkalmazásaik
ITMI20121472A1 (it) * 2012-09-04 2014-03-05 Ind Chimica Srl Processo per la preparazione di 11-metilen-18-metilestr-4-en-3,17-dione, utile come intermedio per la sintesi di molecole ad attivita' farmacologica
KR101687061B1 (ko) * 2014-02-25 2016-12-16 순천향대학교 산학협력단 나이에 따른 당뇨병 진단을 위한 글루코코르티코이드 수용체의 검출제제를 포함하는 타입 2 당뇨 진단 키트
CN105017361A (zh) * 2015-07-16 2015-11-04 湖北竹溪人福药业有限责任公司 一种去氢表雄酮的合成方法
CN109985047B (zh) 2017-12-29 2021-07-27 广州市赛普特医药科技股份有限公司 5α-雄甾-3β,5,6β-三醇在制备治疗出血性脑卒中药物中的应用
CN109369761B (zh) * 2018-12-18 2021-01-01 湖南科瑞生物制药股份有限公司 一种去氢甲基睾丸素的制备方法
CN109369760B (zh) * 2018-12-18 2021-01-01 湖南科瑞生物制药股份有限公司 一种制备去氢甲基睾丸素的方法
CN113318114B (zh) 2020-02-28 2023-02-17 广州市赛普特医药科技股份有限公司 小分子化合物在治疗肺上皮细胞损伤和/或血管内皮细胞损伤介导的疾病中的用途
CN114195844B (zh) * 2021-12-29 2023-03-17 湖北武当安泰药业有限公司 一种去氢表雄酮的制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410516B1 (en) 1986-01-09 2002-06-25 President & Fellows Of Harvard College Nuclear factors associated with transcriptional regulation
US5071773A (en) 1986-10-24 1991-12-10 The Salk Institute For Biological Studies Hormone receptor-related bioassays
US4898694A (en) * 1987-11-25 1990-02-06 Schwartz Arthur G 17-Hydroxy-steroids
WO1995010527A1 (en) * 1993-10-13 1995-04-20 Neurocrine Biosciences, Inc. 3,17-dihydroxy-3,7,16 and/or 17-methyl-androst-5-ene compounds, derivatives thereof, and their use
US6545027B1 (en) 1995-06-07 2003-04-08 Eli Lilly And Company Methods of modulating NF-kB transcription factor
US5989835A (en) 1997-02-27 1999-11-23 Cellomics, Inc. System for cell-based screening
US5753266A (en) * 1996-12-03 1998-05-19 Youssefyeh; Parvin Safflower seed powder compositions for the treatment of rheumatoid based arthritic diseases
US20030083231A1 (en) * 1998-11-24 2003-05-01 Ahlem Clarence N. Blood cell deficiency treatment method
US6667299B1 (en) * 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
EP1422234A3 (en) * 1999-03-23 2010-12-08 Harbor BioSciences, Inc. Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone
AU2005211675B2 (en) * 1999-03-23 2009-09-24 Harbor Biosciences, Inc. Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone
AU6444600A (en) * 1999-08-06 2001-03-05 Glaxo Wellcome S.A. New protein
US6864355B1 (en) 2000-05-02 2005-03-08 Yale University Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain
AU7736300A (en) * 1999-09-30 2001-04-30 Hollis-Eden Pharmaceuticals, Inc. Therapeutic treatment of androgen receptor driven conditions
US6593511B1 (en) 2000-05-12 2003-07-15 Bioseek, Inc. Models of chronic and acute inflammatory diseases
JP2004537506A (ja) * 2001-03-01 2004-12-16 ホリス − イーデン ファーマスーティカルズ、 インコーポレイテッド 血液細胞欠乏症を治療するためのある種のステロイドの使用
CA2447431A1 (en) 2001-05-11 2002-11-21 Research Development Foundation Inhibitors of receptor activator of nf-kb and uses thereof
AU2002340119A1 (en) * 2001-10-09 2003-04-22 Immunex Corporation Mammalian c-type lectins
EP2298315A1 (en) * 2002-08-28 2011-03-23 Harbor BioSciences, Inc. Therapeutic treatment methods
CA2500580A1 (en) * 2002-11-07 2004-05-27 Pharmacia & Upjohn Company Llc Processes for preparing c-7 substituted 5-androstenes
US7884196B2 (en) 2004-10-06 2011-02-08 Oliver Lawless Vaccine composition comprising methylated DNA and immunomodulatory motifs

Also Published As

Publication number Publication date
EP2486924A3 (en) 2013-01-09
CN103211821A (zh) 2013-07-24
EP2486924B1 (en) 2018-12-26
DK2486924T3 (da) 2019-03-04
AU2007300404A1 (en) 2008-04-03
EP2486924A2 (en) 2012-08-15
KR20080112413A (ko) 2008-12-24
JP2009534427A (ja) 2009-09-24
EA200802167A1 (ru) 2009-04-28
AU2007300404B2 (en) 2009-12-17
CA2649940A1 (en) 2008-04-03
PL2012773T3 (pl) 2012-12-31
EP2012773A4 (en) 2010-01-13
IL194751A0 (en) 2009-08-03
AU2010201023B2 (en) 2012-02-09
PL2486924T3 (pl) 2019-07-31
ES2710288T3 (es) 2019-04-24
JP5130591B2 (ja) 2013-01-30
EP2012773A2 (en) 2009-01-14
HUE042925T2 (hu) 2019-07-29
AU2010201023A1 (en) 2010-04-08
JP2012255033A (ja) 2012-12-27
WO2008039566A3 (en) 2008-11-27
WO2008039566A2 (en) 2008-04-03
EP2012773B1 (en) 2012-06-20
CA2649940C (en) 2012-08-07
ES2389743T3 (es) 2012-10-31

Similar Documents

Publication Publication Date Title
DK2012773T3 (da) Lægemidler og anvendelser deraf
DK2059535T3 (da) Prlr-specifikt antistof og anvendelser deraf
DK1894567T3 (da) Ledsagende farmaceutiske midler og anvendelse deraf
DK1866339T3 (da) GTR-bindende molekyler og anvendelser heraf
DK2209806T3 (da) Anti-hepcidin-antistoffer og anvendelser deraf
DK2139490T3 (da) Diazo-bicykliske smac-mimetiske stoffer og anvendelser deraf
DK2147096T3 (da) Modificerede faktor-VII-polypeptider og anvendelser deraf
DK2170287T3 (da) Mikropartikler omfattende PCL og anvendelser deraf
DK2170827T3 (da) Indolin-2-oner og aza-indolin-2-oner
DK2142529T3 (da) Trpv1-antagonister og anvendelser deraf
BRPI0717367A2 (pt) Di-hidropirazolonas substituídas e sua aplicação.
DK3292874T3 (da) Anti-mesothelin-immunkonjugater og anvendelser deraf
DK2068887T3 (da) SP35-antistoffer og anvendelser heraf
DK2118140T3 (da) Humancytomegalovirus-neutraliserende antistoffer og anvendelse deraf
DK2388266T3 (da) Fusionsmolekyler og IL-15-varianter
DK1994055T3 (da) Anti-5t4-antistoffer og anvendelser deraf
DK2079485T3 (da) Phenylpropionamidforbindelser og anvendelsen deraf
DK2012839T3 (da) Hidtil ukendte antimikrobielle substrater og anvendelser deraf
DK2220320T3 (da) Forseglet enhed og mellemstykke
DE602007010795D1 (de) Blattsauger und -häcksler
NO20054709L (no) Sammenfoyningssystem og anvendelse av dette
DK2114903T3 (da) Bicykliske pyrimidinoner og anvendelser deraf
DK2001556T3 (da) Thioninium-forbindelser og anvendelse deraf
DK2352509T3 (da) Hla-g-proteiner og farmaceutiske anvendelser deraf
DK2310356T3 (da) Adamantyl-diamid-derivater og anvendelser deraf